Roflumilast: a new agent for the treatment of COPD
Nurse Prescribing,  Clinical Article

Greener N et al. – Nurses should remind patients that the full effects of roflumilast might take several weeks to emerge, and stress the importance of complying with treatment, even if the benefits are not immediately apparent. Common adverse events with roflumilast include diarrhoea, weight loss, nausea, abdominal pain and headache. While future studies need to resolve several outstanding issues, roflumilast seems to be an important new drug for adults with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and frequent exacerbations.

  • Approximately three million people in the UK suffer from chronic obstructive pulmonary disease (COPD).
  • Conventional therapies alleviate symptoms, improve lung function, reduce the risk of exacerbations and enhance quality of life, but COPD still commonly causes considerable morbidity and mortality.
  • Roflumilast (Daxas®) is a recently launched maintenance treatment for adults with severe COPD associated with chronic bronchitis and frequent exacerbations.
  • Roflumilast inhibits phosphodiesterase 4 (PDE4), a second messenger that downregulates many of the inflammatory cells contributing to COPD.
  • In a year–long study that enrolled COPD patients with severe airflow limitation, bronchitic symptoms and a history of exacerbations, roflumilast (500 microgram once daily) increased pre– and post–bronchodilator FEV1 and FVC, while reducing the number of, and increasing the time until, moderate or severe exacerbations.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...

Your Unread Messages in Physician Assistant

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Physician Assistant Articles

1 Dance for Parkinson's: A new framework for research on its physical, mental, emotional, and social benefits Complementary Therapies in Medicine, June 17, 2014    Review Article

2 Dengue outlook for the World Cup in Brazil: An early warning model framework driven by real-time seasonal climate forecasts The Lancet Infectious Diseases, May 27, 2014    Clinical Article

3 Statins in the elderly: an answered question Current Opinion in Cardiology, June 9, 2014    Evidence Based Medicine    Review Article    Clinical Article

4 The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: A cohort study International Journal of Cardiology, June 27, 2014    Clinical Article

5 Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States BMJ, June 24, 2014    Evidence Based Medicine    Clinical Article

6 Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis New England Journal of Medicine, May 21, 2014    Evidence Based Medicine    Clinical Article

7 Yogurt and weight management American Journal of Clinical Nutrition, April 3, 2014    Review Article

8 The role of vitamin supplementation in the prevention of cardiovascular disease events Full Text Clinical Cardiology, May 30, 2014    Free full text    Review Article

9 Consumption of nuts and legumes and risk of stroke: a meta-analysis of prospective cohort studies Nutrition, Metabolism & Cardiovascular Diseases, July 25, 2014    Evidence Based Medicine    Clinical Article

10 Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: A meta-analysis of placebo-controlled randomized trials Pituitary, May 9, 2014    Evidence Based Medicine    Review Article

11 Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study American Journal of Clinical Nutrition, July 2, 2014    Clinical Article

12 Low/No calorie sweetened beverage consumption in the national weight control registry Obesity, July 11, 2014    Clinical Article

13 Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. preventive services task force Annals of Internal Medicine, April 8, 2014    Evidence Based Medicine    Clinical Article

14 Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians’ Health Study II randomized trial American Journal of Clinical Nutrition, July 10, 2014    Clinical Article

15 Extravirgin olive oil consumption reduces risk of atrial fibrillation Circulation, July 1, 2014    Clinical Article

16 Suicide by occupation: Systematic review and meta-analysis The British Journal of Psychiatry, December 11, 2013    Evidence Based Medicine    Review Article

17 Fish consumption and lung cancer risk: systematic review and meta-analysis Nutrition and Cancer, April 18, 2014    Evidence Based Medicine    Review Article

18 Statins and delirium during critical illness: A multicenter, prospective cohort study Critical Care Medicine, July 23, 2014    Clinical Article

19 Association between dietary intakes of PCBs and the risk of obesity: the SUN project Journal of Epidemiology and Community Health, July 11, 2014    Clinical Article

20 Tea consumption and the risk of five major cancers: A dose-response meta-analysis of prospective studies Full Text BMC Cancer, March 18, 2014    Free full text    Evidence Based Medicine    Review Article

Indexed Journals in Physician Assistant: Advance for Physicians Assistants, American Family Physicianmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close